Florida Statutes
Chapter 893 - Drug Abuse Prevention and Control
893.031 - Industrial Exceptions to Controlled Substance Scheduling.


(1) For the purpose of this section, the following meanings of terms shall apply:
(a) “Manufacture” means any process or operation necessary for manufacturing a product.
(b) “Distribution” means any process or operation necessary for distributing a product, including, but not limited to, wholesaling, delivery or transport, and storage.
(c) “Manufacturer of 1,4-Butanediol” means a person who is involved in the manufacture of 1,4-Butanediol for use in the manufacture of an industrial product and who provides that manufactured 1,4-Butanediol to a distributor of 1,4-Butanediol or a manufacturer of an industrial product.
(d) “Distributor of 1,4-Butanediol” means a person who is involved in the distribution of 1,4-Butanediol.
(e) “Manufacturer of gamma-butyrolactone (GBL)” means a person who:
1. Is involved in the manufacture of gamma-butyrolactone (GBL) for use in the manufacture of an industrial product and who provides that manufactured gamma-butyrolactone (GBL) to a distributor of gamma-butyrolactone (GBL) or a manufacturer of an industrial product; and
2. Is in compliance with any requirements to register with the United States Drug Enforcement Administration as a List I Chemical registrant.

(f) “Distributor of gamma-butyrolactone (GBL)” means a person who:
1. Is involved in the distribution of gamma-butyrolactone (GBL); and
2. Is in compliance with any requirements to register with the United States Drug Enforcement Administration as a List I Chemical registrant.

(g) “Manufacturer of an industrial product” means a person who is involved in the manufacture of an industrial product in which that person acquires:
1. 1,4-Butanediol from a manufacturer of 1,4-Butanediol or a distributor of 1,4-Butanediol and who possesses that substance for use in the manufacture of an industrial product; or
2. Gamma-butyrolactone (GBL) from a manufacturer of gamma-butyrolactone (GBL) or a distributor of gamma-butyrolactone (GBL) and who possesses that substance for use in the manufacture of an industrial product.

(h) “Distributor of an industrial product” means a person who is involved in the distribution of an industrial product.
(i) “Industrial product” means a nondrug, noncontrolled finished product that is not for human consumption.
(j) “Finished product” means a product:
1. That does not contain either 1,4-Butanediol or gamma-butyrolactone (GBL); or
2. From which neither 1,4-Butanediol nor gamma-butyrolactone (GBL) can be readily extracted or readily synthesized and which is not sold for human consumption.


(2) 1,4-Butanediol is excepted from scheduling pursuant to s. 893.03(1)(d)1. when that substance is in the possession of:
(a) A manufacturer of 1,4-Butanediol or a distributor of 1,4-Butanediol;
(b) A manufacturer of an industrial product or a distributor of an industrial product; or
(c) A person possessing a finished product.

(3) Gamma-butyrolactone (GBL) is excepted from scheduling pursuant to s. 893.03(1)(d)2. when that substance is in the possession of:
(a) A manufacturer of gamma-butyrolactone (GBL) or a distributor of gamma-butyrolactone (GBL);
(b) A manufacturer of an industrial product or a distributor of an industrial product; or
(c) A person possessing a finished product.

(4) This section does not apply to:
(a) A manufacturer of 1,4-Butanediol or a distributor of 1,4-Butanediol who sells, delivers, or otherwise distributes that substance to a person who is not a distributor of 1,4-Butanediol or a manufacturer of an industrial product;
(b) A manufacturer of gamma-butyrolactone (GBL) or a distributor of gamma-butyrolactone (GBL) who sells, delivers, or otherwise distributes that substance to a person who is not a distributor of gamma-butyrolactone (GBL) or a manufacturer of an industrial product;
(c) A person who possesses 1,4-Butanediol but who is not a manufacturer of 1,4-Butanediol, a distributor of 1,4-Butanediol, a manufacturer of an industrial product, a distributor of an industrial product, or a person possessing a finished product as described in paragraph (2)(c) or paragraph (3)(c);
(d) A person who possesses gamma-butyrolactone (GBL) but who is not a manufacturer of gamma-butyrolactone (GBL), a distributor of gamma-butyrolactone (GBL), a manufacturer of an industrial product, a distributor of an industrial product, or a person possessing a finished product as described in paragraph (2)(c) or paragraph (3)(c);
(e) A person who extracts or synthesizes either 1,4-Butanediol or gamma-butyrolactone (GBL) from a finished product as described in subparagraph(1)(j)2. or a person who extracts or synthesizes 1,4-Butanediol or gamma-butyrolactone (GBL) from any product or material, unless such extraction or synthesis is authorized by law; or
(f) A person whose possession of either 1,4-Butanediol or gamma-butyrolactone (GBL) is not in compliance with the requirements of this section or whose possession of either of those substances is not specifically authorized by law.

History.—s. 1, ch. 2003-10.

Structure Florida Statutes

Florida Statutes

Title XLVI - Crimes

Chapter 893 - Drug Abuse Prevention and Control

893.01 - Short Title.

893.015 - Statutory References.

893.02 - Definitions.

893.03 - Standards and Schedules.

893.0301 - Death Resulting From Apparent Drug Overdose; Reporting Requirements.

893.031 - Industrial Exceptions to Controlled Substance Scheduling.

893.033 - Listed Chemicals.

893.035 - Control of New Substances; Findings of Fact; Delegation of Authority to Attorney General to Control Substances by Rule.

893.0355 - Control of Scheduled Substances; Delegation of Authority to Attorney General to Reschedule Substance, or Delete Substance, by Rule.

893.0356 - Control of New Substances; Findings of Fact; “Controlled Substance Analog” Defined.

893.04 - Pharmacist and Practitioner.

893.05 - Practitioners and Persons Administering Controlled Substances in Their Absence.

893.055 - Prescription Drug Monitoring Program.

893.0551 - Public Records Exemption for the Prescription Drug Monitoring Program.

893.06 - Distribution of Controlled Substances; Order Forms; Labeling and Packaging Requirements.

893.065 - Counterfeit-Resistant Prescription Blanks for Controlled Substances Listed in Schedule Ii, Schedule Iii, Schedule Iv, or Schedule V.

893.07 - Records.

893.08 - Exceptions.

893.09 - Enforcement.

893.10 - Burden of Proof; Photograph or Video Recording of Evidence.

893.101 - Legislative Findings and Intent.

893.105 - Testing and Destruction of Seized Substances.

893.11 - Suspension, Revocation, and Reinstatement of Business and Professional Licenses.

893.12 - Contraband; Seizure, Forfeiture, Sale.

893.13 - Prohibited Acts; Penalties.

893.135 - Trafficking; Mandatory Sentences; Suspension or Reduction of Sentences; Conspiracy to Engage in Trafficking.

893.1351 - Ownership, Lease, Rental, or Possession for Trafficking in or Manufacturing a Controlled Substance.

893.138 - Local Administrative Action to Abate Certain Activities Declared Public Nuisances.

893.145 - “Drug Paraphernalia” Defined.

893.146 - Determination of Paraphernalia.

893.147 - Use, Possession, Manufacture, Delivery, Transportation, Advertisement, or Retail Sale of Drug Paraphernalia, Specified Machines, and Materials.

893.149 - Unlawful Possession of Listed Chemical.

893.1495 - Retail Sale of Ephedrine and Related Compounds.

893.15 - Rehabilitation.

893.165 - County Alcohol and Other Drug Abuse Treatment or Education Trust Funds.

893.20 - Continuing Criminal Enterprise.

893.21 - Alcohol-Related or Drug-Related Overdoses; Medical Assistance; Immunity From Arrest, Charge, Prosecution, and Penalization.

893.30 - Controlled Substance Safety Education and Awareness.